Julianne Hull BSc, MSc

Julianne has over 25 years’ clinical development experience and has held global leadership roles in vendor management/outsourcing and clinical operations for large and medium sized pharmaceutical companies (Pfizer, Wyeth, Marion Merrell Dow, Biogen Idec and Ipsen). She has been an accomplished manager and motivator of staff based in China, India, Japan, Europe and the US. At Wyeth, she developed, implemented and managed the key cross-functional governance body to drive successful delivery for inspection ready clinical trials.

In 2003, she strategically developed and implemented unique, quality and cost effective clinical data management outsourcing methods, which helped establish the ground breaking Wyeth Accenture strategic alliance. In 2010, she had business and operational oversight of the Wyeth/Accenture alliance through Pfizer’s acquisition of Wyeth. She had critical roles at Wyeth, Biogen Idec and Ipsen to develop and implement effective service provider governance. She is an active member of the Drug Information Association, having been programme chair of the clinical forum in Paris in 2015 and receiving an award for service to the pharmaceutical industry in 2013. Since 2006, she has been on the advisory board of the Informa partnerships conference and is an honorary life member of the Association for Clinical Data Management. She is the owner and Chief Executive Officer of WenStar Enterprises Ltd, which provides clinical outsourcing and operations consultancy services to the pharmaceutical industry.